Ads
-
Related paper
- Therapeutic Response of Black Africans in the Treatment of Genotype 2 Chronic Viral Hepatitis c by Pegylated Interferon-ribavirin
- Vitiligo Associated With Pegylated Interferon and Ribavirin Treatment of Patients With Chronic Hepatitis C
- Pegylated Interferon Alfa 2a Treatment in Patients with Chronic Hepatitis B and Genotype D in Jordan
- GAMMA GLUTAMYL TRANSFERASE IN PREDICTION OF E ARLY V IROLOGICAL R ESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY
- Serum Anti-Interferon Alpha Antibodies in Chronic Hepatitis C Patients Treated with Pegylated Interferon Alpha Containing Therapy
- Host Factors Influences on Treatment Response in Chronic Hepatitis C Patients Treated with pegINF and Ribavirin in Albania
- Role of Dendritic Cells in Chronic HCV Infection and its Correlation with Interferon and Ribavirin Treatment Outcomes
- The level of expression of miR-196a in patients with chronic viral hepatitis C with the first genotype of HCV according to previous experience of antiviral therapy
- Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis
- AN OPEN LABEL, UN-CONTROLLED TRIAL OF SOFOSBUVIR AND RIBAVIRIN COMBINATION THERAPY IN PLACE OF INTERFERON THERAPY IN CHILDREN WITH UNTREATED HEPATITIS C INFECTION